HLA-B27 and antigen presentation: At the crossroads between immune defense and autoimmunity

Molecular Immunology

Volumn 57, Issue 1, 2014, Pages 22-27

  Sorrentino, Rosa ^a   Böckmann, Rainer A ^b   Fiorillo, Maria Teresa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Ankylosing spondylitis; Antigen presentation; Autoimmunity; HLA B27; Micropolymorphism; Molecular dynamics simulation

Indexed keywords

HLA B27 ANTIGEN;

ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTATION; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; GENETIC ASSOCIATION; IMMUNITY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SPONDYLOARTHROPATHY;

ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTATION; AUTOIMMUNITY; HLA-B27; MICROPOLYMORPHISM; MOLECULAR DYNAMICS SIMULATION;

ANTIGEN PRESENTATION; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; HLA-B27 ANTIGEN; HUMANS; PROTEIN BINDING; SPONDYLITIS, ANKYLOSING;

EID: 84884412625     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.06.017     Document Type: Review

References (47)

1. Allen R.L., O'Callaghan C.A., McMichael A.J., Bowness P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. Journal of Immunology 1999, 162:5045-5048.
2. Almeida J.R., Price D.A., Papagno L., Arkoub Z.A., Sauce D., Bornstein E., Asher T.E., Samri A., Schnuriger A., Theodorou I., Costagliola D., Rouzioux C., Agut H., Marcelin A.G., Douek D., Autran B., Appay V. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. Journal of Experimental Medicine 2007, 204:2473-2485.
3. Alvarez I., Martí M., Vázquez J., Camafeita E., Ogueta S., López de Castro J.A. The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation. Journal of Biological Chemistry 2001, 276:48740-48747.
4. Apel M., Uebe S., Bowes J., Giardina E., Korendowych E., Juneblad K., Pasutto F., Ekici A.B., McManus R., Ho P., et al. Variants in RUNX3 contribute to susceptibility to psoriatic arthritis exhibiting further common ground with ankylosing spondylitis. Arthritis & Rheumatism 2013, doi: 10.1002/art.37885.
5. Appel H., Kuon W., Kuhne M., Hülsmeyer M., Kollnberger S., Kuhlmann S., Weiss E., Zeitz M., Wucherpfennig K., Bowness P., Sieper J. The solvent-inaccessible Cys67 residue of HLA-B27 contributes to T cell recognition of HLA-B27/peptide complexes. Journal of Immunology 2004, 173:6564-6573.
6. Appel H., Kuhne M., Spiekermann S., Ebhardt H., Grozdanovic Z., Köhler D., Dreimann M., Hempfing A., Rudwaleit M., Stein H., Metz-Stavenhagen P., Sieper J., Loddenkemper C. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis & Rheumatism 2006, 54:2845-2851.
7. Ben Dror L., Barnea E., Beer I., Mann M., Admon A. The HLA-B*2705 peptidome. Arthritis & Rheumatism 2010, 62:420-429.
8. Benjamin R., Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunology Today 1990, 11:137-142.
9. Bettosini F., Fiorillo M.T., Magnacca A., Leone L., Torrisi M.R., Sorrentino R. The C terminus of the nucleoprotein of influenza A virus delivers antigens transduced by Tat to the trans-Golgi network and promotes an efficient presentation through HLA class I. Journal of Virology 2005, 79:15537-15546.
10. Boon A.C., De Mutsert G., Fouchier R.A., Sintnicolaas K., Osterhaus A.D., Rimmelzwaan G.F. Preferential HLA usage in the influenza virus-specific CTL response. Journal of Immunology 2004, 172:4435-4443.
11. Brewerton D.A., Hart F.D., Nicholls A., Caffrey M., James D.C., Sturrock R.D. Ankylosing spondylitis and HL-A 27. Lancet 1973, 1:904-907.
12. Brooks J.M., Murray R.J., Thomas W.A., Kurilla M.G., Rickinson A.B. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. Journal of Experimental Medicine 1993, 178:879-887.
13. Cascino I., Paladini F., Belfiore F., Cauli A., Angelini C., Fiorillo M.T., Mathieu A., Sorrentino R. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia. Arthritis & Rheumatism 2007, 56:2640-2651.
14. Chen H., Ndhlovu Z.M., Liu D., Porter L.C., Fang J.W., Darko S., Brockman M.A., Miura T., Brumme Z.L., Schneidewind A., Piechocka-Trocha A., Cesa K.T., Sela J., Cung T.D., Toth I., Pereyra F., Yu X.G., Douek D.C., Kaufmann D.E., Allen T.M., Walker B.D. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nature Immunology 2012, 13:691-700.
15. Costello P., Bresnihan B., O'Farrelly C., FitzGerald O. Predominance of CD8+ T lymphocytes in psoriatic arthritis. Journal of Rheumatology 1999, 26:1117-1124.
16. D'Amato M., Fiorillo M.T., Carcassi C., Mathieu A., Zuccarelli A., Bitti P.P., Tosi R., Sorrentino R. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. European Journal of Immunology 1995, 25:3199-3201.
17. Díaz-Peña R., López-Vázquez A., López-Larrea C. Old and new HLA associations with ankylosing spondylitis. Tissue Antigens 2012, 80:205-213.
18. Elahi S., Dinges W.L., Lejarcegui N., Laing K.J., Collier A.C., Koelle D.M., McElrath M.J., Horton H. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nature Medicine 2011, 17:989-995.
19. Evans D.M., Spencer C.C., Pointon J.J., Su Z., Harvey D., Kochan G., Oppermann U., Dilthey A., Pirinen M., Stone M.A., Appleton L., et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genetics 2011, 43:761-767.
20. Fabian H., Huser H., Narzi D., Misselwitz R., Loll B., Ziegler A., Böckmann R.A., Uchanska-Ziegler B., Naumann D. HLA-B27 subtypes differentially associated with disease exhibit conformational differences in solution. Journal of Molecular Biology 2008, 376:798-810.
21. Fabian H., Huser H., Loll B., Ziegler A., Naumann D., Uchanska-Ziegler B. HLA-B27 heavy chains distinguished by a micropolymorphism exhibit differential flexibility. Arthritis & Rheumatism 2010, 62:978-987.
22. Fiorillo M.T., Meadows L., D'Amato M., Shabanowitz J., Hunt D.E., Appella E., Sorrentino R. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. European Journal of Immunology 1997, 27:368-373.
23. Fiorillo M.T., Cauli A., Carcassi C., Bitti P.P., Vacca A., Passiu G., Bettosini F., Mathieu A., Sorrentino R. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis. Arthritis & Rheumatism 2003, 48:1385-1389.
24. Fiorillo M.T., Sorrentino R. T cell responses against viral and self-epitopes and HLA-B27 subtypes differently associated with Ankylosing Spondylitis. Advances in Experimental Medicine and Biology 2009, 649:255-262.
25. François R.J., Neure L., Sieper J., Braun J. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Annals of the Rheumatic Diseases 2006, 65:713-720.
26. Hammer R.E., Maika S.D., Richardson J.A., Tang J.P., Taurog J.D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990, 63:1099-1112.
27. Harari A., Cellerai C., Enders F.B., Köstler J., Codarri L., Tapia G., Boyman O., Castro E., Gaudieri S., James I., John M., Wagner R., Mallal S., Pantaleo G. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:16233-16238.
28. Infantes S., Lorente E., Barnea E., Beer I., Barriga A., Lasala F., Jiménez M., Admon A., López D. Natural HLA-B*2705 ligands with glutamine as anchor motif: implications for HLA-B27 association to spondyloarthropathy. Journal of Biological Chemistry 2013, 288:10882-10889.
29. Kirino Y., Bertsias G., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., Ozyazgan Y., Sacli F.S., Erer B., Inoko H., et al. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nature Genetics 2013, 45:202-207.
30. Leonhardt R.M., Fiegl D., Rufer E., Karger A., Bettin B., Knittler M.R. Post-endoplasmic reticulum rescue of unstable MHC class I requires proprotein convertase PC7. Journal of Immunology 2010, 184:2985-2998.
31. Madden D.R., Gorga J.C., Strominger J.L., Wiley D.C. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991, 353:321-325.
32. Magnacca A., Persiconi I., Nurzia E., Caristi S., Meloni F., Barnaba V., Paladini F., Raimondo D., Fiorillo M.T., Sorrentino R. Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules. Journal of Biological Chemistry 2012, 287:30358-30367.
33. Marcilla M., López de Castro J.A. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens 2008, 71:495-506.
34. Mear J.P., Schreiber K.L., Münz C., Zhu X., Stevanović S., Rammensee H.G., Rowland-Jones S.L., Colbert R.A. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. Journal of Immunology 1999, 163:6665-6670.
35. Narzi D., Becker C.M., Fiorillo M.T., Uchanska-Ziegler B., Ziegler A., Böckmann R.A. Dynamical characterization of two differentially disease associated MHC class I proteins in complex with viral and self-peptides. Journal of Molecular Biology 2012, 415:429-442.
36. Neumann-Haefelin C., McKiernan S., Ward S., Viazov S., Spangenberg H.C., Killinger T., Baumert T.F., Nazarova N., Sheridan I., Pybus O., von Weizsäcker F., Roggendorf M., Kelleher D., Klenerman P., Blum H.E., Thimme R. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 2006, 43:563-572.
37. Nurzia E., Narzi D., Cauli A., Mathieu A., Tedeschi V., Caristi S., Sorrentino R., Böckmann R.A., Fiorillo M.T. Interaction pattern of Arg 62 in the A-pocket of differentially disease-associated HLA-B27 subtypes suggests distinct TCR binding modes. PLoS One 2012, 7:e32865.
38. Powis S.J., Santos S.G., Antoniou A.N. Biochemical features of HLA-B27 and antigen processing. Advances in Experimental Medicine and Biology 2009, 649:210-216.
39. Reveille J.D., Maganti R.M. Subtypes of HLA-B27: history and implications in the pathogenesis of ankylosing spondylitis. Advances in Experimental Medicine and Biology 2009, 649:159-176.
40. Schlosstein L., Terasaki P.I., Bluestone R., Pearson C.M. High association of an HL-A antigen, W27, with ankylosing spondylitis. New England Journal of Medicine 1973, 288:704-706.
41. Schmidt J., Iversen A.K., Tenzer S., Gostick E., Price D.A., Lohmann V., Distler U., Bowness P., Schild H., Blum H.E., Klenerman P., Neumann-Haefelin C., Thimme R. Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope. PLoS Pathogens 2012, 8:e1003042.
42. Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., Allen M.H., Barton A., Band G., Bellenguez C., Bergboer J.G., et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nature Genetics 2010, 42:985-990.
43. Taurog J.D., Dorris M.L., Satumtira N., Tran T.M., Sharma R., Dressel R., van den Brandt J., Reichardt H.M. Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis & Rheumatism 2009, 60:1977-1984.
44. Tenzer S., Wee E., Burgevin A., Stewart-Jones G., Friis L., Lamberth K., Chang C.H., Harndahl M., Weimershaus M., Gerstoft J., Akkad N., Klenerman P., Fugger L., Jones E.Y., McMichael A.J., Buus S., Schild H., van Endert P., Iversen A.K. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nature Immunology 2009, 10:636-646.
45. Uchanska-Ziegler B., Loll B., Fabian H., Hee C.S., Saenger W., Ziegler A. HLA class I-associated diseases with a suspected autoimmune etiology: HLA-B27 subtypes as a model system. European Journal of Cell Biology 2012, 91:274-286.
46. Urban R.G., Chicz R.M., Lane W.S., Strominger J.L., Rehm A., Kenter M.J., UytdeHaag F.G., Ploegh H., Uchanska-Ziegler B., Ziegler A. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:1534-1538.
47. Wong-Baeza I., Ridley A., Shaw J., Hatano H., Rysnik O., McHugh K., Piper C., Brackenbridge S., Fernandes R., Chan A., Bowness P., Kollnberger S. KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA Class I and promotes the expansion of T cells in ankylosing spondylitis. Journal of Immunology 2013, 190:3216-3224.